Código QR (código de barras bidimensional)

Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer

Abstract Introduction The standard treatment for stage III non-small cell lung cancer (NSCLC) is platinum-based concurrent chemoradiotherapy (CCRT), followed by durvalumab (anti-programmed death ligand-1 antibody) maintenance therapy. Biomarkers related to immune-related pneumonitis during durvaluma...

Fuld beskrivelse

Na minha lista:
Principais autores: Ryo Yano, Takaaki Tokito, Kenta Murotani, Daiki Murata, Shingo Tsuneyoshi, Hidenobu Ishii, Koichi Azuma, Tomoaki Hoshino
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2025-12-01
Serier:BMC Cancer
Fag:
Stage III NSCLC
Durvalumab
Pneumonitis
CXCL9
CXCL10
CXCL11
Online adgang:https://doi.org/10.1186/s12885-025-15467-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker